CN114736935A - Method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzyme method - Google Patents
Method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzyme method Download PDFInfo
- Publication number
- CN114736935A CN114736935A CN202210521276.9A CN202210521276A CN114736935A CN 114736935 A CN114736935 A CN 114736935A CN 202210521276 A CN202210521276 A CN 202210521276A CN 114736935 A CN114736935 A CN 114736935A
- Authority
- CN
- China
- Prior art keywords
- hydroxybenzyl
- reaction
- cyclopentanone
- preparing
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 16
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 16
- -1 2- (hydroxybenzyl) cyclopentanone compound Chemical class 0.000 title claims description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- BZKFMUIJRXWWQK-UHFFFAOYSA-N Cyclopentenone Chemical compound O=C1CCC=C1 BZKFMUIJRXWWQK-UHFFFAOYSA-N 0.000 claims abstract description 25
- 239000011259 mixed solution Substances 0.000 claims abstract description 21
- 150000001408 amides Chemical class 0.000 claims abstract description 14
- UWJDDKHDOWAZDA-UHFFFAOYSA-N 2-[hydroxy(phenyl)methyl]cyclopentan-1-one Chemical class C=1C=CC=CC=1C(O)C1CCCC1=O UWJDDKHDOWAZDA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000460 chlorine Chemical group 0.000 claims abstract description 4
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical group [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims abstract description 3
- KFDLHDGFDLHFRW-UHFFFAOYSA-N [O-][N+](Br)=O Chemical group [O-][N+](Br)=O KFDLHDGFDLHFRW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 3
- 150000003935 benzaldehydes Chemical class 0.000 claims abstract 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 28
- 108010084311 Novozyme 435 Proteins 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 19
- 238000004440 column chromatography Methods 0.000 claims description 16
- 229960003966 nicotinamide Drugs 0.000 claims description 14
- 235000005152 nicotinamide Nutrition 0.000 claims description 14
- 239000011570 nicotinamide Substances 0.000 claims description 14
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 9
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical compound NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 6
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 6
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 4
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 4
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 239000003208 petroleum Substances 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 claims 1
- IQHSSYROJYPFDV-UHFFFAOYSA-N 2-bromo-1,3-dichloro-5-(trifluoromethyl)benzene Chemical group FC(F)(F)C1=CC(Cl)=C(Br)C(Cl)=C1 IQHSSYROJYPFDV-UHFFFAOYSA-N 0.000 claims 1
- 238000006555 catalytic reaction Methods 0.000 abstract description 9
- 239000003054 catalyst Substances 0.000 abstract description 8
- 230000035484 reaction time Effects 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 238000005086 pumping Methods 0.000 abstract description 3
- 238000007086 side reaction Methods 0.000 abstract description 2
- 208000012839 conversion disease Diseases 0.000 abstract 1
- 231100000053 low toxicity Toxicity 0.000 abstract 1
- 239000012295 chemical reaction liquid Substances 0.000 description 27
- 238000003786 synthesis reaction Methods 0.000 description 14
- BXRFQSNOROATLV-UHFFFAOYSA-N 4-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=C(C=O)C=C1 BXRFQSNOROATLV-UHFFFAOYSA-N 0.000 description 13
- 230000015572 biosynthetic process Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 12
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine group Chemical group P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 239000012300 argon atmosphere Substances 0.000 description 2
- 239000003426 co-catalyst Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- 238000001308 synthesis method Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- KYVBNYUBXIEUFW-UHFFFAOYSA-N 1,1,3,3-tetramethylguanidine Chemical compound CN(C)C(=N)N(C)C KYVBNYUBXIEUFW-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- ZRYZBQLXDKPBDU-UHFFFAOYSA-N 4-bromobenzaldehyde Chemical compound BrC1=CC=C(C=O)C=C1 ZRYZBQLXDKPBDU-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 description 1
- 238000005712 Baylis-Hillman reaction Methods 0.000 description 1
- 239000007848 Bronsted acid Substances 0.000 description 1
- DRSHXJFUUPIBHX-UHFFFAOYSA-N COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 Chemical compound COc1ccc(cc1)N1N=CC2C=NC(Nc3cc(OC)c(OC)c(OCCCN4CCN(C)CC4)c3)=NC12 DRSHXJFUUPIBHX-UHFFFAOYSA-N 0.000 description 1
- QBXVXKRWOVBUDB-GRKNLSHJSA-N ClC=1C(=CC(=C(CN2[C@H](C[C@H](C2)O)C(=O)O)C1)OCC1=CC(=CC=C1)C#N)OCC1=C(C(=CC=C1)C1=CC2=C(OCCO2)C=C1)C Chemical compound ClC=1C(=CC(=C(CN2[C@H](C[C@H](C2)O)C(=O)O)C1)OCC1=CC(=CC=C1)C#N)OCC1=C(C(=CC=C1)C1=CC2=C(OCCO2)C=C1)C QBXVXKRWOVBUDB-GRKNLSHJSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 150000004808 allyl alcohols Chemical class 0.000 description 1
- SRVFFFJZQVENJC-IHRRRGAJSA-N aloxistatin Chemical compound CCOC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C SRVFFFJZQVENJC-IHRRRGAJSA-N 0.000 description 1
- 229910002056 binary alloy Inorganic materials 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 238000001460 carbon-13 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000012973 diazabicyclooctane Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QAPTWHXHEYAIKG-RCOXNQKVSA-N n-[(1r,2s,5r)-5-(tert-butylamino)-2-[(3s)-2-oxo-3-[[6-(trifluoromethyl)quinazolin-4-yl]amino]pyrrolidin-1-yl]cyclohexyl]acetamide Chemical compound CC(=O)N[C@@H]1C[C@H](NC(C)(C)C)CC[C@@H]1N1C(=O)[C@@H](NC=2C3=CC(=CC=C3N=CN=2)C(F)(F)F)CC1 QAPTWHXHEYAIKG-RCOXNQKVSA-N 0.000 description 1
- 239000012011 nucleophilic catalyst Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012434 nucleophilic reagent Substances 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
- C12P7/38—Cyclopentanone- or cyclopentadione-containing products
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a method for preparing 2- (hydroxybenzyl) cyclopentanone compounds by an enzyme method, which comprises the steps of pumping a mixed solution containing benzaldehyde compounds I, amides and cyclopentenone into a microchannel reaction device, and reacting in a microreactor filled with enzyme to obtain the 2- (hydroxybenzyl) cyclopentanone compounds shown in a formula II, wherein R is selected from nitro, bromine, chlorine and cyano. The method has the advantages of short reaction time, high reaction conversion rate, less side reaction, low toxicity and pollution, low production cost, good product quality and the like, does not use an organic catalyst for catalysis in the reaction process, is environment-friendly, energy-saving and efficient, is suitable for popularization and application, and solves the problems of long reaction time, harsh reaction conditions and the need of the organic catalyst for catalysis in the prior art.
Description
Technical Field
The invention belongs to the field of chemical synthesis, and particularly relates to a method for preparing 2- (hydroxybenzyl) cyclopentanone compounds by an enzymatic method.
Background
2- (hydroxybenzyl) cyclopentanones are highly functionalized allylic alcohols and can be valuable building blocks for the synthesis of complex natural products. (Organic Letters,2006,8(19):4195-4198.) the enol compounds of 2- (hydroxybenzyl) cyclopentanone are also important Organic synthesis intermediates, and have many applications in the synthesis of pharmaceutical related compounds and some complex natural products. (Chemical communications,2009(37):5496-
The 2- (hydroxybenzyl) cyclopentanone compound is mainly obtained through the Morita-Baylis-Hillman reaction according to the literature report at present and is one of the products of the MBH reaction. The main synthesis method of 2- (hydroxybenzyl) cyclopentanone compounds is catalyzed by pyridine, imidazole or other nucleophilic reagents such as tertiary amine, tertiary phosphine and the like according to the patent reports in the literature. For example, the guanidine/oxazole binary system is used to catalyze the MBH reaction to obtain 2- (hydroxybenzyl) cyclopentanone compounds, and the Bronsted acid also provides another method for catalyzing the reaction. In the above-mentioned synthesis method, an organic nucleophilic catalyst is usually required for catalysis, or catalysis is carried out using a tertiary phosphine or the like. The nucleophilic chemical catalyst not only brings environmental hidden trouble, but also increases the cost of the industrial production of the 2- (hydroxybenzyl) cyclopentanone compound.
Disclosure of Invention
The purpose of the invention is as follows: the technical problem to be solved by the invention is to provide a method for preparing 2- (hydroxybenzyl) cyclopentanone compounds by an enzyme method by adopting a micro-channel reactor aiming at the defects of the prior art.
The technical scheme is as follows: in order to solve the technical problem, the invention discloses a method for preparing a 2- (hydroxybenzyl) cyclopentanone compound by adopting a microchannel reactor through an enzyme method, which comprises the steps of pumping a mixed solution containing a benzaldehyde compound I, an amide and cyclopentenone into a microchannel reaction device, and carrying out reaction in a microreactor filled with enzyme to obtain the 2- (hydroxybenzyl) cyclopentanone compound shown as a formula II.
Wherein R is selected from nitro, bromine, chlorine or cyano, preferably R is selected from 4-nitro, 4-bromine, 4-chlorine, 4-cyano; more preferably, R is selected from 4-nitro or 4-chloro.
Preferably, the method comprises the following steps:
the amide is any one or combination of more of formamide, benzamide, acetamide and nicotinamide; more preferably, the amide is nicotinamide.
The solid is calculated by mmol, the liquid is calculated by ml, the dosage ratio of the benzaldehyde compound I, the amide and the cyclopentenone in the mixed solution is 0.1-0.5 mmol: 0.3-1.5 mmol: 2-4 ml; more preferably, the mixed solution contains benzaldehyde compound, amide and cyclopentenone in the ratio of 0.3 mmol: 0.9 mmol: 3 ml.
In the reaction system, cyclopentenone is used as a raw material and a solvent of the reaction at the same time.
The pumping rate of the mixed solution is 0.1-0.15 ml/min; more preferably, the mixed solution is pumped at a rate of 0.125 ml/min.
The microreactor is filled with an enzyme selected from Novozym 435, and the volume after filling is 3-5 ml; more preferably, the microreactors are selected from packed column microreactors, and the volume after refilling with Novozym 435 is 3 ml.
The reaction temperature is 20-70 ℃; more preferably, the reaction temperature is 40 ℃.
The residence time of the reaction is 10-50 min; more preferably, the residence time of the reaction is 24 min.
The diameter of the flow pipe of the micro reactor is 0.1 mm.
After the reaction is finished, the obtained reaction liquid is concentrated and subjected to column chromatography to obtain the 2- (hydroxybenzyl) cyclopentanone compound shown as the formula II.
And an eluent for column chromatography is a mixed solvent of ethyl acetate and petroleum ether according to the volume ratio of 1:2-1: 20.
Has the advantages that: compared with the prior art, the invention has the following advantages:
the method has the advantages of greatly shortened reaction time, less side reaction compared with common chemical catalysis, less toxicity and pollution, low production cost, good product quality and the like, does not use organic catalyst for catalysis in the reaction process, is green, environment-friendly, energy-saving and efficient, is suitable for popularization and application, and solves the problems of long reaction time, harsh reaction conditions and the need of organic catalyst catalysis in the prior art.
Drawings
FIG. 1 is the compound 2- [ hydroxy- (4-nitrophenyl) methyl ] in an example of the present invention]Process for preparing cyclopenten-2-ones1H NMR spectrum.
FIG. 2 is a compound of 2- [ hydroxy- (4-nitrophenyl) methyl ] in an example of the present invention]Process for preparing cyclopenten-2-ones13C NMR spectrum.
FIG. 3 is a schematic view of a reaction apparatus and a flow chart of the present invention.
Detailed Description
The experimental methods described in the following examples are all conventional methods unless otherwise specified; the reagents and materials are commercially available, unless otherwise specified.
In the following examples, benzaldehyde represented by compound I and a 2- (hydroxybenzyl) cyclopentanone compound represented by compound II are shown in Table 1 and Table 2, respectively.
Table 1 reactants: benzaldehyde
TABLE 2 target products
In the following examples, the filled microreactor filled with Novozym 435 had a volume of 3 mL.
Example 1: synthesis of Compound 2a
A solution of 0.3mmol of 4-nitrobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone dissolved in syringe A was injected into a packed microreactor packed with Novozym 435, and the mixture was pumped at a flow rate of 0.125ml/min by a syringe pump and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2a with the yield of 66%. Nuclear magnetic diagrams as shown in figures 1 and 2,1H NMR(400MHz,Chloroform-d)δ8.14(d,J=8.7Hz,2H),7.52(d,J=8.6Hz,2H),7.25(s,1H),5.60(s,1H),3.65(s,1H),2.59–2.54(m,2H),2.41(dd,J=3.8,2.1Hz,2H).13C NMR(101MHz,Chloroform-d)δ209.36,159.95,148.55,146.71,127.11,123.74,68.97,35.16,26.87.
example 2: synthesis of Compound 2b
A solution of 0.3mmol of 4-bromobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min using a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2b, wherein the yield is 54%.
Example 3: synthesis of Compound 2c
A solution of 0.3mmol of 4-chlorobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone dissolved in the syringe A was injected into the packed microreactor filled with Novozym 435, and the mixture was pumped at a flow rate of 0.125ml/min by a syringe pump and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2c with the yield of 60%.
Example 4: synthesis of Compound 2d
A solution containing 0.3mmol of 4-cyanobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min by means of a syringe pump and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain a target product 2d with the yield of 50%.
Example 5: synthesis of Compound 2a
A solution containing 0.3mmol of 4-nitrobenzaldehyde, 0.9mmol of benzamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min using a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2a with the yield of 40%.
Example 6: synthesis of Compound 2a
A solution containing 0.3mmol of 4-nitrobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.1ml/min by a syringe pump and reacted at a temperature of 40 ℃ for 30 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating the target product 2a by column chromatography, wherein the yield is 59%.
Example 7: synthesis of Compound 2a
A solution containing 0.3mmol of 4-nitrobenzaldehyde, 0.9mmol of nicotinamide and 5ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min by using a syringe pump, and reacted at a temperature of 40 ℃ for 40 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2a with the yield of 26%.
Example 8: synthesis of Compound 2a
A solution containing 0.2mmol of 4-nitrobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min by using a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2a with the yield of 52%.
Example 9: synthesis of Compound 2a
A solution containing 0.3mmol of 4-nitrobenzaldehyde, 0.9mmol of nicotinamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min by using a syringe pump, and reacted at a temperature of 30 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2a with the yield of 45%.
Example 10: synthesis of Compound 2a
A solution containing 0.3mmol of 4-nitrobenzaldehyde, 0.3mmol of nicotinamide and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min by using a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, concentrating the collected reaction liquid under reduced pressure, and separating by column chromatography to obtain the target product 2a with the yield of 31%.
Comparative example 1:
a solution of 0.3mmol of 4-nitrobenzaldehyde and 0.9mmol of nicotinamide in 3ml of cyclopentenone was added to a 10ml centrifuge tube, and 50mg of Novozym 435z was added to the mixed solution. Stirring for 48h at 40 ℃ by using a shaking table, and after the reaction is finished, separating and purifying to obtain the target product 2a with the yield of 53%.
By comparing comparative example 1 with example 1, it can be seen that the 48h yield in the conventional reactor is 53% and the 24min target product yield in the microchannel reactor is 66% using the same catalyst system of Novozym 435+ amide. The microchannel reactor can greatly improve the heat transfer and mass transfer of the reaction and improve the reaction efficiency.
Comparative example 2:
injecting 5ml toluene solution dissolved with 0.3mmol 4-nitrobenzaldehyde, 0.9mmol cyclopentenone, 0.03mmol thiourea catalyst (CAS:1014980-03-0) and 0.03mmol DABCO (0.03mmol) into a reaction bottle A, stirring at room temperature under argon atmosphere for 72h, concentrating the reaction solution under reduced pressure after the reaction is finished, and purifying by column chromatography to obtain product 2a with yield of 63%
Compared with the comparative example 2 and the example 1, the method provided by the invention can greatly improve the reaction efficiency and shorten the reaction time compared with the existing method.
Comparative example 3:
injecting a 2ml tetrahydrofuran solution dissolved with 0.3mmol of 4-nitrobenzaldehyde, 0.45mmol of cyclopentenone, 0.03mmol of tetramethylguanidine and 0.45mmol of 1,2, 4-triazole into a reaction bottle A, stirring for 24h at 45 ℃ under argon atmosphere, concentrating the reaction solution under reduced pressure after the reaction is finished, and purifying by column chromatography to obtain a product 2a with the yield of 55 percent
Compared with the prior art, the method provided by the invention has the advantages that the reaction efficiency can be greatly improved, the reaction time can be shortened, and the used catalyst is a more green biocatalyst.
Comparative example 4:
a solution containing 0.3mmol of 4-nitrobenzaldehyde and 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped into a packed microreactor packed with Novozym 435 at a flow rate of 0.125ml/min using a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, and concentrating the collected reaction liquid under reduced pressure to obtain the target product 2 a.
By comparing comparative example 4 with example 1, it can be found that the objective product cannot be obtained without using an amide as a co-catalyst. Indicating that the amide is essential for the catalysis of the reaction.
Comparative example 5:
a solution of 0.3mmol of 4-nitrobenzaldehyde and 0.9mmol of nicotinamide in 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped at a flow rate of 0.125ml/min into an empty tube of a packed microreactor not filled with Novozym 435 by means of a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, and concentrating the collected reaction liquid under reduced pressure to obtain the target product 2 a.
Comparative example 6:
a solution of 0.3mmol of 4-nitrobenzaldehyde in 3ml of cyclopentenone was injected into a syringe A, and the mixed solution was pumped at a flow rate of 0.125ml/min into an empty tube of a packed microreactor not packed with Novozym 435 using a syringe pump, and reacted at a temperature of 40 ℃ for 24 min. And collecting the reaction liquid flowing out of the microreactor, and concentrating the collected reaction liquid under reduced pressure to obtain the target product 2 a.
By comparing comparative example 6 with example 1, and by combining comparative example 4, comparative example 5 can find that the desired product is not obtained without using Novozym 435 as a co-catalyst. It is shown that a co-catalytic system of amide and enzyme is necessary for the catalysis of the reaction, and that the use of Novozym 435 alone or amide can not independently catalyze the reaction, and the target product can be obtained only under the combined catalytic scheme provided by the scheme.
The invention discloses a method and a thought for preparing a 2- (hydroxybenzyl) cyclopentanone compound by an enzyme method by using a microchannel reactor, and a method and a way for realizing the technical scheme are many. All the components not specified in the present embodiment can be realized by the prior art.
Claims (10)
1. A method for preparing 2- (hydroxybenzyl) cyclopentanone compounds by an enzyme method is characterized in that a mixed solution containing benzaldehyde compounds I, amides and cyclopentenone is pumped into a microchannel reaction device and reacts in a microreactor filled with enzyme to obtain the 2- (hydroxybenzyl) cyclopentanone compounds shown in a formula II;
wherein R is selected from nitro, bromine, chlorine or cyano.
2. The method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzymatic process according to claim 1, wherein R is selected from 4-nitro, 4-bromo, 4-chloro or 4-cyano.
3. The method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzyme method according to claim 1, wherein the amide is any one or combination of formamide, benzamide, acetamide and nicotinamide.
4. The method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzyme method according to claim 1, wherein the benzaldehyde compound II, the amide and the cyclopentenone are used in a ratio of 0.1-0.5 in the mixed solution, wherein solid is mmol and liquid is ml: 0.3-1.5: 2-4.
5. The method for preparing 2- (hydroxybenzyl) cyclopentanone according to claim 1, characterized in that the mixed solution is pumped at a rate of 0.1 to 0.15 ml/min.
6. The method for preparing 2- (hydroxybenzyl) cyclopentanone compounds by enzymatic method according to claim 1, wherein the microreactor is filled with an enzyme selected from Novozym 435 in a volume of 3-5 ml.
7. The method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzymatic method according to claim 1, wherein the temperature of the reaction is 20-70 ℃.
8. The method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzymatic process according to claim 1, characterized in that the residence time of the reaction is 20-50 min.
9. The method for preparing 2- (hydroxybenzyl) cyclopentanone compounds according to claim 1, wherein the 2- (hydroxybenzyl) cyclopentanone compound represented by formula II is obtained by concentrating the obtained reaction solution after the reaction is completed and performing column chromatography.
10. The method for preparing 2- (hydroxybenzyl) cyclopentanone compound by enzymatic method according to claim 9, wherein the eluent for column chromatography is a mixed solvent of ethyl acetate and petroleum ether at a volume ratio of 1:2 to 1: 20.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210521276.9A CN114736935B (en) | 2022-05-13 | 2022-05-13 | Method for preparing 2- (hydroxy benzyl) cyclopentanone compound by enzyme method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210521276.9A CN114736935B (en) | 2022-05-13 | 2022-05-13 | Method for preparing 2- (hydroxy benzyl) cyclopentanone compound by enzyme method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114736935A true CN114736935A (en) | 2022-07-12 |
CN114736935B CN114736935B (en) | 2024-04-26 |
Family
ID=82284919
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210521276.9A Active CN114736935B (en) | 2022-05-13 | 2022-05-13 | Method for preparing 2- (hydroxy benzyl) cyclopentanone compound by enzyme method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114736935B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112062706A (en) * | 2020-10-26 | 2020-12-11 | 南京先进生物材料与过程装备研究院有限公司 | Method for continuously preparing indolone compounds by using microchannel reaction device |
CN112209907A (en) * | 2020-10-21 | 2021-01-12 | 南京先进生物材料与过程装备研究院有限公司 | Method for synthesizing dihydrofuran containing 1, 3-indene dione spiro-skeleton by using microchannel reaction device |
CN113444752A (en) * | 2021-07-15 | 2021-09-28 | 南京工业大学 | Method for continuously preparing 2-benzyl isoindolinone compound by adopting microchannel reactor |
US20220033863A1 (en) * | 2020-10-22 | 2022-02-03 | Fudan University | Continuous flow method for preparing (r)-3-hydroxy-5-hexenoate |
CN114213201A (en) * | 2022-01-05 | 2022-03-22 | 南京工业大学 | Method for obtaining MBH reaction product by catalysis of microchannel reactor |
-
2022
- 2022-05-13 CN CN202210521276.9A patent/CN114736935B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112209907A (en) * | 2020-10-21 | 2021-01-12 | 南京先进生物材料与过程装备研究院有限公司 | Method for synthesizing dihydrofuran containing 1, 3-indene dione spiro-skeleton by using microchannel reaction device |
US20220033863A1 (en) * | 2020-10-22 | 2022-02-03 | Fudan University | Continuous flow method for preparing (r)-3-hydroxy-5-hexenoate |
CN112062706A (en) * | 2020-10-26 | 2020-12-11 | 南京先进生物材料与过程装备研究院有限公司 | Method for continuously preparing indolone compounds by using microchannel reaction device |
CN113444752A (en) * | 2021-07-15 | 2021-09-28 | 南京工业大学 | Method for continuously preparing 2-benzyl isoindolinone compound by adopting microchannel reactor |
CN114213201A (en) * | 2022-01-05 | 2022-03-22 | 南京工业大学 | Method for obtaining MBH reaction product by catalysis of microchannel reactor |
Non-Patent Citations (2)
Title |
---|
ANITA ŠALIĆ AND BRUNO ZELIĆ: "Synergy of Microtechnology and Biotechnology: Microreactors as an Effective Tool for Biotransformation Processes", 《FOOD TECHNOLOGY AND BIOTECHNOLOGY》, vol. 56, no. 4, 30 November 2018 (2018-11-30), pages 464 - 479, XP055979702, DOI: 10.17113/ftb.56.04.18.5673 * |
MASAYA MIYAZAKI等: "Microchannel enzyme reactors and their applications for processing", 《TRENDS IN BIOTECHNOLOGY》, vol. 24, no. 10, 28 August 2006 (2006-08-28), pages 463 - 470 * |
Also Published As
Publication number | Publication date |
---|---|
CN114736935B (en) | 2024-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112979461A (en) | Full continuous flow preparation method of 3-chloro-4-oxoacetic acid amyl ester | |
CN111560624B (en) | Method for continuously preparing isobenzofuran compounds by using microchannel reaction device | |
CN111205279B (en) | Polysubstituted benzodihydrofuran heterocyclic compound and preparation method and application thereof | |
WO2023109968A3 (en) | Synthesis method for finerenone and intermediate thereof | |
CN113264845A (en) | Method for continuously preparing chloramphenicol by using micro-reaction system | |
CN114262296B (en) | Method for synthesizing imidazole compounds by utilizing micro-channel reaction device | |
CN114213201B (en) | Method for obtaining MBH reaction product by catalysis of microchannel reactor | |
CN113584099B (en) | Method for preparing dihydrocoumarin or derivative thereof by adopting micro-flow field reaction technology | |
CN111056934A (en) | Method for preparing α -hydroxyketone photoinitiator in microreactor | |
CN114736935B (en) | Method for preparing 2- (hydroxy benzyl) cyclopentanone compound by enzyme method | |
CN108084050A (en) | A kind of aluminium phosphate molecular sieve is catalyzed imines synthetic method | |
CN113620824B (en) | Method for realizing N-H insertion reaction of diazo acid ester compound and aniline molecule by utilizing photocatalytic microchannel | |
CN114805081B (en) | Method for rapidly preparing 1-naphthylamine based on micro-channel continuous flow technology | |
CN112876330A (en) | Method for continuously preparing bibenzyl by using microchannel reaction device | |
CN104744187A (en) | Method for preparing alkene compound in microchannel reactor through aldehyde compound | |
CN113354495A (en) | Difluorone carbonyl substituted asymmetric nitrile compound and preparation and application thereof | |
CN113801079B (en) | Synthetic method of dinotefuran metabolite UF | |
CN114524777B (en) | Synthesis method of dihydro-oxazole compound | |
CN115490613B (en) | Preparation method of aromatic nitrile compound | |
CN113234000A (en) | Method for continuously preparing alpha-ketothioester by using microchannel reaction device | |
CN114891019B (en) | Continuous flow preparation method of vinyl thioether compound | |
CN113636952B (en) | Method for preparing 4-bromobenzamide | |
CN111187165A (en) | Method for continuously preparing allyl ester by using microchannel reaction device | |
CN118834143A (en) | Method for preparing methacrylonitrile by continuous flow process | |
CN118026851A (en) | Micro-channel preparation method of o-nitrobenzaldehyde |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |